Brief: Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes
23/09/2026 22:14
BRIEF-Viking Therapeutics Announces Proposed Offerings Of Common Stock And Convertible Senior Notes Sept 24 (Reuters) - Viking Therapeutics, Inc. VKTX.O:
VIKING THERAPEUTICS ANNOUNCES PROPOSED OFFERINGS OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES
VIKING THERAPEUTICS, - TO OFFER $200 MILLION COMMON STOCK AND $200 MILLION CONVERTIBLE NOTES DUE 2032
VIKING THERAPEUTICS, - PROCEEDS TO FUND VK2735, VK3019 CLINICAL DEVELOPMENT AND GENERAL CORPORATE PURPOSES
Source text: ID:nPn9Vc5vVa
Further company coverage: VKTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viking Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry